FundedIQ
Biotechnology

Tympanogen, Inc.: Funding, Investors & Team (Oct 2026)

Tympanogen develops novel materials to improve treatment outcomes and decrease healthcare costs for otolaryngologists and their patients. Its flagship product, Perf-Fix, is the first gel patch for nonsurgical eardrum repair.

www.tympanogen.com LinkedIn Richmond, United States 1-10 employees
Total raised
$700k
Rounds
2
Latest
Undisclosed round
Apr 2022

Tympanogen, Inc. has raised $700k across 2 funding rounds on record, the most recent an undisclosed round announced in Apr 2022.

Tympanogen, Inc. Company Profile and Key Stats

Total funding raised
$700k
across 2 rounds on record
Funding rounds on record
2
1 with no disclosed amount
Latest funding round
Undisclosed round
Apr 2022
Employees
1-10
reported band
Headquarters
Richmond, United States

Latest funding round on record: Apr 2022.

Tympanogen, Inc. Funding Rounds

Date
Round
Amount
Undisclosed round
Undisclosed
Grant
$700k

1 of 2 rounds was announced without a disclosed amount and is excluded from the total.

Tympanogen, Inc. raised $700k in a Grant announced in Nov 2021.

5 months later, an undisclosed round was announced in Apr 2022 with no disclosed amount.

Tympanogen, Inc. Founders and Leadership Team

Name
Role
Contact
Elaine Horn-Ranney
CEO
Locked

Contact details for the Tympanogen, Inc. team: 1 of 1 has an email address on file.

Start 14-day free trial →

Tympanogen, Inc. Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Funded Startups Like Tympanogen, Inc. in Biotechnology and Richmond

Companies Similar to Tympanogen, Inc.

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Tympanogen, Inc. Funding FAQs

What does Tympanogen, Inc. do?

Tympanogen develops novel materials to improve treatment outcomes and decrease healthcare costs for otolaryngologists and their patients. Its flagship product, Perf-Fix, is the first gel patch for nonsurgical eardrum repair.

How much funding has Tympanogen, Inc. raised?

Tympanogen, Inc. has raised $700k across 2 rounds on record.

When did Tympanogen, Inc. last raise funding?

Tympanogen, Inc.'s most recent funding round on record was announced in Apr 2022. The amount was not disclosed.

Who is the CEO of Tympanogen, Inc.?

Elaine Horn-Ranney is listed as CEO at Tympanogen, Inc..

Where is Tympanogen, Inc. headquartered?

Tympanogen, Inc. is based in Richmond, Virginia, United States.

How many employees does Tympanogen, Inc. have?

Tympanogen, Inc. is in the 1-10 employee band.

About FundedIQ's Tympanogen, Inc. Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tympanogen, Inc. is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.